White Paper: Laboratory Developed Tests: Overview of the Regulatory Framework in Europe vs. USA
[dpvfw_pdf_viewer_embed pdfviewer=”13199″ _builder_version=”4.27.0″ _module_preset=”default” global_colors_info=”{}”...
Traditional CROs fragment device development with costly hand-offs and learning curves. Veranex unites the essential disciplines for medical device & diagnostic development under one roof from sketch to evidence-generation to market launch.
All connected. All aligned. All accelerating your path to market—delivering breakthrough devices and diagnostics that improve patient lives sooner.
Breakthrough innovation requires more than great solutions; it demands deep expertise and insight. Veranex packages outcome-driven solutions with 25+ years of specialized knowledge across major medtech categories, delivering integrated capabilities that solve your most pressing challenges faster and with greater certainty.
Purpose-built solutions. Proven results. User & Patient-centered innovation.
Whether you're transforming patient care or disrupting entire therapeutic categories, innovation requires more than great science, it demands velocity. Veranex was founded to bridge the gap between visionary concepts and market reality, combining proven expertise with agile execution to accelerate the innovations that matter most.
We are the Innovation CRO.
Legacy of excellence. Proven execution. Patient impact accelerated.
One in five Americans will develop skin cancer in their lifetime, and this ratio will continue to grow as generations continue to age. As a result, it’s become increasingly difficult for patients to schedule an appointment with a dermatologist, which contributes to disease progression and increased stress for the patients.
3Derm is a Boston-based technology startup focused on optimizing the dermatology care process. 3Derm aspired to increase dermatology patient access to care by creating a hand-held stereoscopic imaging system for remote skin monitoring. Initial efforts to marry their software with iPhone cameras resulted in a high number of false negatives. After realizing that commercial cameras were incapable of producing the images necessary for an accurate diagnosis, 3Derm turned to Veranex (formerly Ximedica) to develop an integrated software and imaging device.
3Derm elicited Veranex’s expertise in:
[dpvfw_pdf_viewer_embed pdfviewer=”13199″ _builder_version=”4.27.0″ _module_preset=”default” global_colors_info=”{}”...
In this white paper, our regulatory team presents the frameworks governing Laboratory Developed Tests in Europe and the USA, and discuss...